MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Atomik Labz
122 products · 249 listings
Daily snapshot · inspect sources
Capsule comparison
Tesofensine Capsules prices
Compare Tesofensine Capsules listings by strength, selection and supplier. Inspect the original source behind each price.
2suppliers represented
2source-linked listings
1strengths available
GO BEYOND THE PRICE
Track it. Plan it. Inspect it.
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Reports and batch records
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Listed amounts and selections
- 0.5 mg2 suppliers · Pack counts: 60
Reported quantities in this family: 60. Counts and units must be matched to the exact listing.
Compare the exact selection
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.
Suppliers with Tesofensine Capsules listings
2 profiles
Solution Peptides
153 products · 275 listings
Sources and comparison limits
2 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
Explore more capsule listings
FROM PEPTIDES CALCULATOR
About Tesofensine
Source profile reviewed 2026-10-02 · Imported 2026-10-22. Read the full compound profile
Tesofensine (NS2330) is an oral triple monoamine reuptake inhibitor that was first tested in Alzheimer's and Parkinson's disease and then developed for obesity, where it reduces appetite and food craving. In a Danish phase 2 trial 0.5 mg a day produced about 9% weight loss over 24 weeks, and a 372-patient phase 3 trial run by Medix in Mexico reported about 10%, but as of October 2026 it is not approved anywhere: Mexico's regulator withheld approval in November 2024 and Medix resubmitted a revised dossier in February 2025. Saniona also tests it combined with metoprolol, as Tesomet, for hypothalamic obesity.
- Formula
- C17 H23 Cl2 N O
- Molar mass
- 328.3 g/mol
- CAS number
- 195875-84-4
Research evidence described in the source
Human studies and registrations
3 protocol rows on this page come from human trials, trial registrations, regulator labels or reviews of human data. Approval status and populations are stated per row.
Community-reported use
2 rows record what blogs, vendor write-ups or forums describe for Tesofensine. None has been verified against primary literature.
Limitations noted in the source
- Every amount on this page is a report of what a source describes, not a protocol to follow.
- Preclinical and community rows do not establish a human amount, schedule or route.
- Formulation, purity and presentation vary by supplier and are not covered by the dossier.
Publications and references linked by the source
- pubchem.ncbi.nlm.nih.gov/compound/11370864
- pubmed.ncbi.nlm.nih.gov/18950853/
- center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi
- www.globenewswire.com/news-release/2018/12/17/1667781/0/en/Saniona-s-tesofensine-meets-primary-and-secondary-endpoints-in-Phase-3-obesity-registration-trial.html
- pubmed.ncbi.nlm.nih.gov/35294397/
- www.inderes.se/en/releases/update-on-tesofensine-application
- www.inderes.dk/en/releases/medix-has-resubmitted-tesofensine-application-to-cofepris
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.